Key Drivers
- Strong Margins
- Weak Liquidity
- Rising Debt
AIAI Summary
CLX should be viewed less as a defensive staples compounder and more as a high-risk normalization story: with cash flow weakening, leverage and liquidity deteriorating, and legal scrutiny rising, the stock likely remains under pressure unless ERP disruption fades quickly and FY27 margin/EPS recovery starts to show up in results.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Margins
- •Weak Liquidity
- •Rising Debt
Clorox still generates strong margins and full-year cash flow, but rising debt, negative equity, and weak recent cash flow make its leveraged balance sheet the main risk despite a steady dividend.
Price Behavior
Key Price Behavior Insights:
- •Downtrend intact
- •Oversold rebound
- •Resistance overhead
CLX has been in a clear downtrend over the last month, but its rebound from the ~$86 selloff low into $90–92 is constructive while it remains capped below $96–97, keeping the near-term setup cautious .
A sharp ~12% drop was followed by a rebound from the ~$86 low into the $90–92 range
Sentiment & News
Key News Insights:
- •Valuation Support
- •Margin Pressure
- •Legal Scrutiny
CLX looks attractively valued with a strong dividend, but recent earnings, guidance cuts, margin pressure, and shareholder investigations keep near-term risk elevated.
The stock may stay range-bound to weaker until cost pressures ease and legal overhangs fade, despite long-term upside from its dividend and low valuation
Similar Companies in Consumer Defensive
Other companies in the same sector with AI ratings